Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China
· Delayed Price · Currency is CNY 38.92
-0.38 (-0.97%)
Apr 30, 2025, 3:00 PM CST
Hangzhou Biotest Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Operating Revenue | 512.85 | 560.59 | 435.93 | 1,894 | 1,811 | 855.9 | Upgrade
|
| Other Revenue | - | - | 6.18 | 7.23 | 7.09 | 9.47 | Upgrade
|
| Revenue | 512.85 | 560.59 | 442.11 | 1,901 | 1,818 | 865.37 | Upgrade
|
| Revenue Growth (YoY) | 8.18% | 26.80% | -76.74% | 4.57% | 110.09% | 314.37% | Upgrade
|
| Cost of Revenue | -27.52 | - | 269.6 | 940.21 | 705.47 | 242.57 | Upgrade
|
| Gross Profit | 540.37 | 560.59 | 172.51 | 960.93 | 1,113 | 622.8 | Upgrade
|
| Selling, General & Admin | 7.16 | - | 79.21 | 86.09 | 69.63 | 42.36 | Upgrade
|
| Research & Development | 0.47 | - | 80.48 | 108.21 | 61.92 | 41.32 | Upgrade
|
| Other Operating Expenses | 360.87 | 358.76 | 5.46 | 19.49 | 16.84 | 9.69 | Upgrade
|
| Operating Expenses | 368.51 | 358.76 | 168.81 | 208.2 | 151.61 | 96.6 | Upgrade
|
| Operating Income | 171.86 | 201.83 | 3.7 | 752.73 | 961 | 526.2 | Upgrade
|
| Interest Expense | - | - | -0.14 | -0.19 | -0.68 | -0.47 | Upgrade
|
| Interest & Investment Income | 1.94 | - | 76.9 | 51.91 | 15.36 | 1.4 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 13.07 | 111.92 | -15.48 | -17.16 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.6 | 1.51 | -0.59 | -1.1 | -0.87 | -0.67 | Upgrade
|
| EBT Excluding Unusual Items | 168.19 | 203.34 | 92.95 | 915.26 | 959.34 | 509.3 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.01 | - | - | 0.06 | 0.84 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.28 | - | 0 | - | - | -0.03 | Upgrade
|
| Asset Writedown | 0.34 | - | -6.35 | -18.78 | -0 | -0 | Upgrade
|
| Other Unusual Items | - | - | 29.27 | 5.35 | 8.45 | 5.06 | Upgrade
|
| Pretax Income | 168.27 | 203.34 | 115.88 | 901.9 | 968.63 | 514.33 | Upgrade
|
| Income Tax Expense | 23.47 | 26.66 | 10.58 | 128.33 | 132.87 | 79.36 | Upgrade
|
| Earnings From Continuing Operations | 144.8 | 176.68 | 105.3 | 773.56 | 835.76 | 434.97 | Upgrade
|
| Minority Interest in Earnings | 0.98 | - | 1.31 | 0.07 | -2.17 | 0.18 | Upgrade
|
| Net Income | 145.78 | 176.68 | 106.61 | 773.63 | 833.59 | 435.15 | Upgrade
|
| Net Income to Common | 145.78 | 176.68 | 106.61 | 773.63 | 833.59 | 435.15 | Upgrade
|
| Net Income Growth | 8.52% | 65.73% | -86.22% | -7.19% | 91.56% | 1441.52% | Upgrade
|
| Shares Outstanding (Basic) | 106 | 105 | 107 | 107 | 87 | 80 | Upgrade
|
| Shares Outstanding (Diluted) | 106 | 105 | 107 | 107 | 87 | 80 | Upgrade
|
| Shares Change (YoY) | 0.71% | -1.35% | -0.10% | 23.15% | 8.33% | -0.01% | Upgrade
|
| EPS (Basic) | 1.37 | 1.68 | 1.00 | 7.25 | 9.62 | 5.44 | Upgrade
|
| EPS (Diluted) | 1.37 | 1.68 | 1.00 | 7.25 | 9.62 | 5.44 | Upgrade
|
| EPS Growth | 7.76% | 68.00% | -86.21% | -24.64% | 76.84% | 1454.29% | Upgrade
|
| Free Cash Flow | - | - | 74.96 | 524.29 | 707.92 | 388.38 | Upgrade
|
| Free Cash Flow Per Share | - | - | 0.70 | 4.91 | 8.17 | 4.86 | Upgrade
|
| Dividend Per Share | - | - | 0.800 | 2.200 | 3.000 | - | Upgrade
|
| Dividend Growth | - | - | -63.64% | -26.67% | - | - | Upgrade
|
| Gross Margin | 105.37% | 100.00% | 39.02% | 50.54% | 61.20% | 71.97% | Upgrade
|
| Operating Margin | 33.51% | 36.00% | 0.84% | 39.59% | 52.86% | 60.81% | Upgrade
|
| Profit Margin | 28.43% | 31.52% | 24.11% | 40.69% | 45.85% | 50.28% | Upgrade
|
| Free Cash Flow Margin | - | - | 16.95% | 27.58% | 38.94% | 44.88% | Upgrade
|
| EBITDA | - | 225.73 | 27.6 | 772.63 | 969.2 | 531.69 | Upgrade
|
| EBITDA Margin | - | 40.27% | 6.24% | 40.64% | 53.31% | 61.44% | Upgrade
|
| D&A For EBITDA | - | 23.9 | 23.9 | 19.9 | 8.2 | 5.48 | Upgrade
|
| EBIT | 171.86 | 201.83 | 3.7 | 752.73 | 961 | 526.2 | Upgrade
|
| EBIT Margin | 33.51% | 36.00% | 0.84% | 39.59% | 52.86% | 60.81% | Upgrade
|
| Effective Tax Rate | 13.95% | 13.11% | 9.13% | 14.23% | 13.72% | 15.43% | Upgrade
|
| Revenue as Reported | - | - | 442.11 | 1,901 | 1,818 | 865.37 | Upgrade
|
| Advertising Expenses | - | - | 4.21 | 3.19 | 1.63 | 2.41 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.